Stephanie Palazzolo writes at The Information: OpenAI is taking steps to improve its audio AI models, in preparation for its eventual release of an AI-powered personal device, said a person with ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...

OpenAI has moved production of its first AI-powered consumer device from Luxshare to Foxconn, largely due to concerns about manufacturing in mainland China, reported Taiwan-based outlet UDN, citing ...

The FDA on Thursday approved a transcranial direct current stimulation (tDCS) device as the first at-home non-drug therapy for major depression in adults, maker Flow Neuroscience announced. Dubbed ...

Holly™ by Nephrodite becomes the first device to achieve the designation, marking a major regulatory milestone toward first-in-human clinical studies Nephrodite, Inc., a medical device company ...

The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side ...

Two of the biggest brands in modern DJing, Serato and AlphaTheta, have teamed up to launch SLAB, the first-ever MIDI pad controller created exclusively with Serato users in mind. The drop builds on a ...

In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...

WASHINGTON — The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can ...

The FDA has approved the first at -home brain-stimulation device for adults with major depressive disorder (MDD). The FL-100 transcranial direct-current stimulation (tDCS) system (Flow Neuroscience) ...